Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Diabet Med ; 41(3): e15210, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37634222

ABSTRACT

AIMS: While peer support research is growing in the Type 1 diabetes (T1D) community, the peer supporter training (PST) process is rarely documented in detail. This study provides a comprehensive description of PST and evaluation for the REACHOUT mental health support intervention, and examines the feasibility and perceived utility of PST. METHODS: Fifty-three adults with T1D were recruited to participate in a 6-hour, zoom-based PST program for mental health support. The program was structured in three parts: (1) internal motivation, resilience and empathy; (2) mindfulness, emotions and diabetes distress; and (3) active listening and deferring clinical questions to professionals. Candidates were evaluated based on eight pre-established competency criteria during a 5-day support trial with an assigned standardized T1D participant. Perceived usefulness of training skills was also assessed 3 months into the REACHOUT mental health support intervention. RESULTS: Fifty-one of the fifty-three candidates who completed training achieved the criteria to graduate. Mean scores for the eight competency domains were: listens actively (4.55); asks open-ended questions (4.12); expresses empathy (4.42); avoids passing judgment (4.67); sits with strong emotions (4.44); refrains from giving advice (4.38); makes reflections (4.5); and defers medical questions (4.58). Of the skills learned during the PST, 95% rated interpreting and discussing diabetes distress profile and expressing empathy as moderately to extremely useful. CONCLUSIONS: Findings demonstrate that it is feasible to recruit and graduate the number of trainees needed using a rigorous process. Only by making training protocols available can the PST be replicated and translated to other T1D populations (e.g. adolescents, parents of children with T1D).


Subject(s)
Diabetes Mellitus, Type 1 , Mobile Applications , Adult , Child , Adolescent , Humans , Diabetes Mellitus, Type 1/therapy , Mental Health , Language , Parents
2.
Can J Diabetes ; 48(1): 59-65.e1, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37802366

ABSTRACT

OBJECTIVE: Our aim in this study was to determine the safety, glycemia, and quality of life (QoL) associated with in-clinic installation and management of supported open-source artificial pancreas systems (SOSAPS) in type 1 diabetes (T1D). METHODS: This investigation is a retrospective cohort study of consecutive SOSAPS users at a Canadian diabetes centre. SOSAPS were offered to all moderately tech-savvy T1D clients on sensor-augmented multiple daily injection or pump, able to pay for hardware, and willing to sign a consent and waiver document. SOSAPS were installed and maintained by clinic staff at no cost to clients. iPhone users were assigned to either Loop (n=108) or iPhone artificial pancreas systems (iAPS; n=114) and Android users to Android-type APS (n=24). Outcomes included severe hypoglycemia and diabetic ketoacidosis (DKA), time in range (TIR) 4.0 to 10.0 mmol/L, time below range (TBR) <4 mmol/L, glucose management indicator (GMI), mean sensor glucose (MSG), change in glycated hemoglobin (A1C), and QoL. RESULTS: Two hundred forty-eight subjects (131 males, 117 females), with a mean age of 36 years and diabetes duration of 21 years, experienced 3 episodes of severe hypoglycemia and no DKA over a follow-up of 17 months. TIR rose by 16%, from 64% to 80% (p<0.0001); TBR fell by 1.0%, from 3.5% to 2.5% (p=0.001); MSG fell from 9.0 to 8.1 mmol/L (p<0.001); GMI fell from 7.3% to 6.7% (p<0.001); and A1C fell from 7.2% to 6.7% (p<0.0001). QoL scores were healthy before and improved after SOSAPS. CONCLUSIONS: Clients with T1D using SOSAPS and supported with no-cost care to the client (software, technology, and physician/physician assistant) safely achieved improved TIR, GMI, A1C, and QoL.


Subject(s)
Diabetes Mellitus, Type 1 , Diabetic Ketoacidosis , Hypoglycemia , Pancreas, Artificial , Male , Female , Humans , Adult , Diabetes Mellitus, Type 1/drug therapy , Hypoglycemic Agents/therapeutic use , Glycated Hemoglobin , Quality of Life , Insulin/therapeutic use , Retrospective Studies , Insulin Infusion Systems , Canada/epidemiology , Hypoglycemia/prevention & control , Hypoglycemia/complications , Diabetic Ketoacidosis/epidemiology , Diabetic Ketoacidosis/prevention & control , Diabetic Ketoacidosis/complications , Blood Glucose Self-Monitoring , Glucose , Blood Glucose
3.
J Clin Nurs ; 17(16): 2146-54, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18705736

ABSTRACT

AIMS AND OBJECTIVES: The aims were to explore advanced practice nurses' perceptions on wireless Personal Digital Assistant technologies, to establish the type and range of tools that would be useful to support their practice and to identify any requirements and limitations that may impact the implementation of wireless Personal Digital Assistants in practice. BACKGROUND: The wireless Personal Digital Assistant is becoming established as a hand-held computing tool for healthcare professionals. The reflections of advanced practice nurses' about the value of wireless Personal Digital Assistants and its potential to contribute to improved patient care has not been investigated. DESIGN: A qualitative interpretivist design was used to explore advanced practice nurses' perceptions on the value of wireless Personal Digital Assistant technologies to support their practice. METHODS: The data were collected using survey questionnaires and individual and focus group interviews with nurse practitioners, clinical nurse specialists and information technology managers based in British Columbia, Canada. An open-coding content analysis was performed using qualitative data analysis software. RESULTS: Wireless Personal Digital Assistant's use supports the principles of pervasivity and is a technology rapidly being adopted by advanced practice nurses. Some nurses indicated a reluctance to integrate wireless Personal Digital Assistant technologies into their practices because of the cost and the short technological life cycle of these devices. Many of the barriers which precluded the use of wireless networks within facilities are being removed. Nurses demonstrated a complex understanding of wireless Personal Digital Assistant technologies and gave good rationales for its integration in their practice. CONCLUSIONS: Nurses identified improved client care as the major benefit of this technology in practice and the type and range of tools they identified included clinical reference tools such as drug and diagnostic/laboratory reference applications and wireless communications. RELEVANCE TO CLINICAL PRACTICE: Nurses in this study support integrating wireless mobile computing technologies into their practice to improve client care.


Subject(s)
Attitude of Health Personnel , Attitude to Computers , Computers, Handheld , Nurse Clinicians/psychology , Nurse Practitioners/psychology , British Columbia , Computer Literacy , Data Collection , Decision Support Systems, Clinical , Drug Information Services , Focus Groups , Health Knowledge, Attitudes, Practice , Humans , Medical Records Systems, Computerized , Motivation , Nurse Clinicians/education , Nurse Clinicians/organization & administration , Nurse Practitioners/education , Nurse Practitioners/organization & administration , Nurse's Role/psychology , Nursing Methodology Research , Qualitative Research , Quality of Health Care , Surveys and Questionnaires , Technology Assessment, Biomedical , Time Management , Workload
4.
Can J Diabetes ; 41(3): 297-304, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28318938

ABSTRACT

OBJECTIVES: To examine the effects of a 6-month nurse case manager (NCM) intervention compared to standard care (SC) on glycemic control and diabetes distress in a Canadian tertiary-care setting. METHODS: We recruited 140 adults with type 2 diabetes and glycated hemoglobin (A1C) levels >8% (64 mmol/mol) from 2 tertiary care facilities and randomized them to: 1) a 6-month NCM intervention in addition to SC or 2) SC by the primary endocrinologists. Assessments were conducted at baseline and at 6 months. Primary outcomes included A1C levels and diabetes distress scores (DDS). Secondary outcomes included body mass index, blood pressure, diabetes-related behaviour measures, depressive symptoms, self-motivation and perception of support. RESULTS: At the 6-month follow up, the NCM group experienced larger reductions in A1C levels of -0.73% compared to the SC group (p=0.027; n=134). The NCM group also showed an additional reduction of -0.40 (26% reduction) in DDS compared to those in the SC group (p=0.001; n=134). The NCM group had lower blood pressure, ate more fruit and vegetables, exercised more, checked their feet more frequently, were more motivated, were less depressed and perceived more support. There were no changes and no group differences in terms of body mass index, medication compliance or frequency of testing. CONCLUSIONS: Compared to SC, NCM intervention was more effective in improving glycemic control and reducing diabetes distress. It is, therefore, a viable adjunct to standard diabetes care in the tertiary care setting, particularly for patients at high risk and with poor control.


Subject(s)
Case Management/trends , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/therapy , Nurse's Role , Tertiary Healthcare/methods , Tertiary Healthcare/trends , Aged , Canada/epidemiology , Diabetes Mellitus, Type 2/blood , Female , Follow-Up Studies , Glycemic Index/physiology , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL